Frédéric Bost
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- Metabolism, Diabetes, and Cancer
- PI3K/AKT/mTOR signaling in cancer
- Melanoma and MAPK Pathways
Papers in
-
- Metabolism, Diabetes, and Cancer 22
- PI3K/AKT/mTOR signaling in cancer 10
- Protein Kinase Regulation and GTPase Signaling 7
- Melanoma and MAPK Pathways 7
-
- Cancer, Hypoxia, and Metabolism 14
- Co-authors
- Y. Le Marchand‐Brustel (15 shared papers)Jean‐François Tanti (24 shared papers)Bernard Binétruy (14 shared papers)Issam Ben Sahra (7 shared papers)Kathiane Laurent (15 shared papers)Leslie Caron (10 shared papers)Myriam Aouadi (8 shared papers)Sophie Giorgetti‐Peraldi (7 shared papers)
- Journals
- Journal of Biological Chemistry (6 papers)Oncogene (3 papers)Oncotarget (3 papers)Cancer Research (3 papers)European Journal of Biochemistry (3 papers)
- Partner nations
- FranceUnited StatesMonaco
In The Last Decade
Frédéric Bost
87 papers receiving 6.8k citations
Frédéric Bost's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 1.4k
- Molecular Biology 4.6k
- Oncology 1.2k
- Physiology 901
- Geriatrics and Gerontology 116
Countries citing papers authored by Frédéric Bost
This map shows the geographic impact of Frédéric Bost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Bost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Bost more than expected).
Fields of papers citing papers by Frédéric Bost
This network shows the impact of papers produced by Frédéric Bost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Bost. The network helps show where Frédéric Bost may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Bost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level Hit paper breakdown → | 2008 | 746 |
| 2 | Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1 Hit paper breakdown → | 2011 | 534 |
| 3 | 2004 | 488 | |
| 4 | 2010 | 453 | |
| 5 | 2010 | 429 | |
| 6 | 2005 | 281 | |
| 7 | 2008 | 229 | |
| 8 | 1997 | 209 | |
| 9 | 1998 | 188 | |
| 10 | 2006 | 164 | |
| 11 | 2002 | 164 | |
| 12 | 1998 | 160 | |
| 13 | 1997 | 158 | |
| 14 | 2010 | 137 | |
| 15 | 2012 | 135 | |
| 16 | 1999 | 133 | |
| 17 | 2006 | 124 | |
| 18 | 2002 | 123 | |
| 19 | C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. | 2003 | 109 |
| 20 | 2010 | 102 |
About Frédéric Bost
Frédéric Bost is a scholar working on Molecular Biology, Cancer Research, Oncology, Physiology and Surgery, having authored 95 papers that have together received 6.9k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (22 papers), Cancer, Hypoxia, and Metabolism (14 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Cancer-related Molecular Pathways (10 papers), Adipose Tissue and Metabolism (9 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Melanoma and MAPK Pathways (7 papers) and Pancreatic function and diabetes (7 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (4.6k citations), Oncology (1.2k citations), Physiology (901 citations) and Geriatrics and Gerontology (116 citations). Frédéric Bost has collaborated with scholars based in France, United States and Monaco. Frequent co-authors include Y. Le Marchand‐Brustel, Jean‐François Tanti, Bernard Binétruy, Issam Ben Sahra, Kathiane Laurent, Leslie Caron, Myriam Aouadi, Sophie Giorgetti‐Peraldi, Patrick Auberger and Dan Mercola. Their work appears in journals such as Journal of Biological Chemistry, Oncogene, Oncotarget, Cancer Research and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.